Natco Pharma gets EIR from USFDA for Kothur’s formulation facility

Natco Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524816 | NSE: NATCOPHARM

25 Apr 2020 Evaluate

Natco Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, India, during the period from March 2nd to March 6th, 2020.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Peers

Company Name	CMP
Sun Pharma. Inds.	1842.00
Dr. Reddys Labs.	1161.00
Cipla	1365.00
Lupin	2096.00
Zydus Lifesciences	1119.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.